Company intelligence / Profile preview
Aperture Therapeutics
San Carlos, California, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
The company is pre-clinical and has not yet reported clinical results. Its approach centers on using genetically diverse stem cell libraries to identify new therapeutic candidates for age-related neurodegenerative diseases.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculesStem cell-based screening platforms
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Aperture Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aperture Therapeutics.